Biomerica
BMRA
7 hedge funds and large institutions have $199K invested in Biomerica in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
11% more capital invested
Capital invested by funds: $179K → $199K (+$20K)
0.01% less ownership
Funds ownership: 0.12% → 0.11% (-0.01%)
30% less funds holding
Funds holding: 10 → 7 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$14K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1K |
BMRA Hedge Fund Activity: Q2 2017 in Review
7 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q2 2017, worth a combined $199K — up 11% from $179K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BMRA and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Millennium Management, cutting an estimated $14K.
- 7 institutional investors held Biomerica (BMRA) as of Q2 2017, down from 10 in Q1 2017.
- Funds reported $199K of Biomerica stock for Q2 2017, up 11% quarter-over-quarter.
- 0 funds opened new Biomerica positions in Q2 2017 and 3 closed out, a net change of -3 holders.
- The largest Biomerica seller in Q2 2017 was Millennium Management, an estimated $14K sold.
Based on aggregated 13F filings for Q2 2017.